| scholarly article | Q13442814 |
| P50 | author | Kurt H. Albertine | Q67004583 |
| P2093 | author name string | S Li | |
| D R Davis | |||
| T L Stemmler | |||
| U K von Schwedler | |||
| W I Sundquist | |||
| V Y Klishko | |||
| P2860 | cites work | Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells | Q36651389 |
| Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein | Q36653772 | ||
| Sequences in the U5-gag-pol region influence early and late pathogenic effects of Friend and Moloney murine leukemia viruses | Q36805717 | ||
| The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors | Q36881276 | ||
| HIV-1 nucleocapsid protein induces "maturation" of dimeric retroviral RNA in vitro | Q37427179 | ||
| Active foamy virus proteinase is essential for virus infectivity but not for formation of a Pol polyprotein | Q38290008 | ||
| Distinct signals in human immunodeficiency virus type 1 Pr55 necessary for RNA binding and particle formation | Q38323895 | ||
| In vitro assembly properties of purified bacterially expressed capsid proteins of human immunodeficiency virus | Q38341673 | ||
| The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity | Q39870242 | ||
| In vitro assembly of virus-like particles with Rous sarcoma virus Gag deletion mutants: identification of the p10 domain as a morphological determinant in the formation of spherical particles | Q39879873 | ||
| The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions. | Q40042979 | ||
| Mutagenesis of protease cleavage sites in the human immunodeficiency virus type 1 gag polyprotein | Q40059062 | ||
| Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity. | Q40115512 | ||
| Structure-based inhibitors of HIV-1 protease | Q40835286 | ||
| Cryo-electron microscopy reveals ordered domains in the immature HIV-1 particle | Q41079116 | ||
| Intracellular transport of retroviral capsid components. | Q41100808 | ||
| HIV-1 Reverse Transcription A Termination Step at the Center of the Genome | Q41443092 | ||
| Structure of crystalline -chymotrypsin. II. A preliminary report including a hypothesis for the activation mechanism | Q41524722 | ||
| Studies on the immunogenicity of Chinese hamster ovary cell-derived recombinant gp120 (HIV-1IIIB). | Q41701443 | ||
| Analysis of non-infectious HIV particles produced in presence of HIV proteinase inhibitor | Q41702922 | ||
| Identification of protein intermediates in the processing of the p55 HIV-1 gag precursor in cells infected with recombinant vaccinia virus | Q43691016 | ||
| Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficiency virus type-1 preparations | Q45763504 | ||
| Evolution of retroposons by acquisition or deletion of retrovirus-like genes | Q46084667 | ||
| Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes | Q46558825 | ||
| Progressive alignment of amino acid sequences and construction of phylogenetic trees from them | Q46794683 | ||
| Structural similarity between the p17 matrix protein of HIV-1 and interferon-γ | Q57065085 | ||
| Form, function, and use of retroviral gag proteins | Q67961638 | ||
| Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease | Q69564852 | ||
| Differential antibody responses of individuals infected with AIDS-associated retroviruses surveyed using the viral core antigen p25gag expressed in bacteria | Q70131045 | ||
| Structure of the amino-terminal core domain of the HIV-1 capsid protein | Q71142552 | ||
| Molecular recognition in the HIV-1 capsid/cyclophilin A complex | Q73511357 | ||
| Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1 | Q24609814 | ||
| Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides | Q24627225 | ||
| The Nef protein of human immunodeficiency virus type 1 enhances serine phosphorylation of the viral matrix | Q24673997 | ||
| The use of lead citrate at high pH as an electron-opaque stain in electron microscopy | Q26778439 | ||
| Crystal structure of SIV matrix antigen and implications for virus assembly | Q27729336 | ||
| Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein | Q27730770 | ||
| Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly | Q27732646 | ||
| Crystal structure of dimeric HIV-1 capsid protein | Q27733334 | ||
| Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid | Q27734262 | ||
| Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein | Q27746461 | ||
| Rapid and efficient site-specific mutagenesis without phenotypic selection | Q27860628 | ||
| Use of T7 RNA polymerase to direct expression of cloned genes | Q27860692 | ||
| Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions | Q27860828 | ||
| Determination of the structure of the nucleocapsid protein NCp7 from the human immunodeficiency virus type 1 by 1H NMR | Q28289627 | ||
| Production of high-titer helper-free retroviruses by transient transfection | Q29547802 | ||
| Backbone 1H and 15N resonance assignments of the N-terminal SH3 domain of drk in folded and unfolded states using enhanced-sensitivity pulsed field gradient NMR techniques | Q29614703 | ||
| Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene | Q29615351 | ||
| Hydrophobic interactions control zymogen activation in the trypsin family of serine proteases | Q30423680 | ||
| HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import. | Q33887160 | ||
| Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein | Q33887338 | ||
| Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1. | Q34304675 | ||
| Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations | Q34423807 | ||
| Immunologic and proteolytic analysis of HIV-1 reverse transcriptase structure | Q34558243 | ||
| Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase | Q35237118 | ||
| Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity. | Q35830898 | ||
| The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses | Q35866801 | ||
| The role of Gag in human immunodeficiency virus type 1 virion morphogenesis and early steps of the viral life cycle | Q35873645 | ||
| Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17. | Q35882404 | ||
| Zinc- and sequence-dependent binding to nucleic acids by the N-terminal zinc finger of the HIV-1 nucleocapsid protein: NMR structure of the complex with the Psi-site analog, dACGCC. | Q36277807 | ||
| Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions | Q36624873 | ||
| Functional domains of the capsid protein of human immunodeficiency virus type 1 | Q36638060 | ||
| Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles. | Q36650046 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | proteolysis | Q33123 |
| refolding | Q3935998 | ||
| P304 | page(s) | 1555-1568 | |
| P577 | publication date | 1998-03-01 | |
| P1433 | published in | The EMBO Journal | Q1278554 |
| P1476 | title | Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly | |
| P478 | volume | 17 |
| Q38279481 | A molecular switch required for retrovirus assembly participates in the hexagonal immature lattice |
| Q37780981 | A new functional role of HIV-1 integrase during uncoating of the viral core |
| Q40468566 | A novel fluorescence resonance energy transfer assay demonstrates that the human immunodeficiency virus type 1 Pr55Gag I domain mediates Gag-Gag interactions. |
| Q33220259 | A peptide inhibitor of HIV-1 assembly in vitro |
| Q35113684 | A retroviral chimeric capsid protein reveals the role of the N-terminal β-hairpin in mature core assembly |
| Q35750243 | A second-site suppressor significantly improves the defective phenotype imposed by mutation of an aromatic residue in the N-terminal domain of the HIV-1 capsid protein |
| Q34771244 | A sensitive assay using a native protein substrate for screening HIV-1 maturation inhibitors targeting the protease cleavage site between the matrix and capsid |
| Q40311599 | A small loop in the capsid protein of Moloney murine leukemia virus controls assembly of spherical cores |
| Q42546287 | A strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycle |
| Q33755116 | ATPgammaS disrupts human immunodeficiency virus type 1 virion core integrity |
| Q40159851 | Allosteric HIV-1 Integrase Inhibitors Lead to Premature Degradation of the Viral RNA Genome and Integrase in Target Cells |
| Q92689634 | Allosteric Regulation of HIV-1 Capsid Structure for Gag Assembly, Virion Production, and Viral Infectivity by a Disordered Interdomain Linker |
| Q33834585 | Alteration of zinc-binding residues of simian immunodeficiency virus p8(NC) results in subtle differences in gag processing and virion maturation associated with degradative loss of mutant NC. |
| Q33687232 | Amino-acid co-variation in HIV-1 Gag subtype C: HLA-mediated selection pressure and compensatory dynamics |
| Q51740197 | An RNA-binding compound that stabilizes the HIV-1 gRNA packaging signal structure and specifically blocks HIV-1 RNA encapsidation. |
| Q41893327 | An extensive thermodynamic characterization of the dimerization domain of the HIV-1 capsid protein. |
| Q33874074 | Analysis of Mason-Pfizer monkey virus Gag domains required for capsid assembly in bacteria: role of the N-terminal proline residue of CA in directing particle shape |
| Q40653610 | Analysis of the retrovirus capsid interdomain linker region |
| Q44380725 | Antiviral inhibition of the HIV-1 capsid protein |
| Q30455050 | Assembly and architecture of HIV. |
| Q33809649 | Assembly of retrovirus capsid-nucleocapsid proteins in the presence of membranes or RNA. |
| Q40676680 | Assembly properties of the human immunodeficiency virus type 1 CA protein |
| Q35920838 | Atomic Modeling of an Immature Retroviral Lattice Using Molecular Dynamics and Mutagenesis |
| Q34172241 | Atomic force microscopy and electron microscopy analysis of retrovirus Gag proteins assembled in vitro on lipid bilayers |
| Q36571972 | Backbone 15N relaxation analysis of the N‐terminal domain of the HTLV‐I capsid protein and comparison with the capsid protein of HIV‐1 |
| Q27652542 | Biochemical and Structural Studies of Yeast Vps4 Oligomerization |
| Q37396540 | Biological stimuli and biomolecules in the assembly and manipulation of nanoscale polymeric particles |
| Q34606804 | Biophysical characterization of the feline immunodeficiency virus p24 capsid protein conformation and in vitro capsid assembly |
| Q33912010 | Capsid processing requirements for abrogation of Fv1 and Ref1 restriction |
| Q36845921 | Capsid proteins from human immunodeficiency virus type 1 and simian immunodeficiency virus SIVmac can coassemble into mature cores of infectious viruses. |
| Q33865636 | Characterization of Rous sarcoma virus Gag particles assembled in vitro |
| Q39873195 | Characterization of a myristoylated, monomeric HIV Gag protein |
| Q37155570 | Characterization of the in vitro HIV-1 capsid assembly pathway |
| Q39756191 | Characterization of the invariable residue 51 mutations of human immunodeficiency virus type 1 capsid protein on in vitro CA assembly and infectivity |
| Q35019967 | Charged assembly helix motif in murine leukemia virus capsid: an important region for virus assembly and particle size determination |
| Q38703585 | Comparison of Biochemical Properties of HIV-1 and HIV-2 Capsid Proteins |
| Q35024004 | Compensatory substitutions restore normal core assembly in simian immunodeficiency virus isolates with Gag epitope cytotoxic T-lymphocyte escape mutations |
| Q35212464 | Conformation and dynamics of the Gag polyprotein of the human immunodeficiency virus 1 studied by NMR spectroscopy. |
| Q35785819 | Conformation of the HIV-1 Gag protein in solution. |
| Q44019101 | Conformational stability of dimeric and monomeric forms of the C-terminal domain of human immunodeficiency virus-1 capsid protein |
| Q36961899 | Conservation of a stepwise, energy-sensitive pathway involving HP68 for assembly of primate lentivirus capsids in cells |
| Q59358666 | Conserved cysteines in Mason-Pfizer monkey virus capsid protein are essential for infectious mature particle formation |
| Q45471635 | Conserved serines in simian immunodeficiency virus capsid are required for virus budding |
| Q39991984 | Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative |
| Q36776033 | Cooperative role of the MHR and the CA dimerization helix in the maturation of the functional retrovirus capsid |
| Q40182244 | Correct capsid assembly mediated by a conserved YXXLGL motif in prototype foamy virus Gag is essential for infectivity and reverse transcription of the viral genome |
| Q52563013 | Critical Role of the HTLV-1 Capsid N-Terminal Domain for Gag-Gag Interactions and Virus Particle Assembly. |
| Q36673166 | Critical role of conserved hydrophobic residues within the major homology region in mature retroviral capsid assembly. |
| Q27683857 | Cryo-electron microscopy of tubular arrays of HIV-1 Gag resolves structures essential for immature virus assembly |
| Q30276365 | Crystal structure of an HIV assembly and maturation switch. |
| Q30425900 | Design of in vitro symmetric complexes and analysis by hybrid methods reveal mechanisms of HIV capsid assembly |
| Q35154296 | Determinants of the HIV-1 core assembly pathway. |
| Q36325523 | Direct measurement of Gag-Gag interaction during retrovirus assembly with FRET and fluorescence correlation spectroscopy |
| Q27678471 | Distinct Effects of Two HIV-1 Capsid Assembly Inhibitor Families That Bind the Same Site within the N-Terminal Domain of the Viral CA Protein |
| Q34717899 | Distinct roles for nucleic acid in in vitro assembly of purified Mason-Pfizer monkey virus CANC proteins |
| Q27663032 | Disulfide bond stabilization of the hexameric capsomer of human immunodeficiency virus |
| Q92623235 | Dominant Negative MA-CA Fusion Protein Is Incorporated into HIV-1 Cores and Inhibits Nuclear Entry of Viral Preintegration Complexes |
| Q42688106 | Dominant negative inhibition of human immunodeficiency virus particle production by the nonmyristoylated form of gag. |
| Q37348096 | Dual-acting stapled peptides target both HIV-1 entry and assembly |
| Q36330057 | Early stages of the HIV-1 capsid protein lattice formation |
| Q27324193 | Ebselen, a Small-Molecule Capsid Inhibitor of HIV-1 Replication. |
| Q33614514 | Effect of dimerizing domains and basic residues on in vitro and in vivo assembly of Mason-Pfizer monkey virus and human immunodeficiency virus. |
| Q39612608 | Effect of macromolecular crowding agents on human immunodeficiency virus type 1 capsid protein assembly in vitro. |
| Q34302140 | Effects of Gag mutation and processing on retroviral dimeric RNA maturation |
| Q35542805 | Effects of blocking individual maturation cleavages in murine leukemia virus gag. |
| Q33805303 | Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain |
| Q30479297 | Electron cryotomography of immature HIV-1 virions reveals the structure of the CA and SP1 Gag shells |
| Q45407731 | Evolution of feline immunodeficiency virus Gag proteins |
| Q52672702 | Expression, Purification and Characterization of Hiv-1 Capsid Precursor Protein p41. |
| Q40700631 | Expression, purification, and characterization of an anti-RBCFab-p24 fusion protein for hemagglutination-based rapid detection of antibodies to HIV in whole blood |
| Q37683431 | Fitness costs limit viral escape from cytotoxic T lymphocytes at a structurally constrained epitope |
| Q27644938 | Flexibility in HIV-1 Assembly Subunits: Solution Structure of the Monomeric C-Terminal Domain of the Capsid Protein |
| Q34364648 | Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication |
| Q39748566 | Functional Surfaces of the Human Immunodeficiency Virus Type 1 Capsid Protein |
| Q31523975 | Functional characterization of the human immunodeficiency virus type 1 genome by genetic footprinting |
| Q34237075 | Fundamental differences between the nucleic acid chaperone activities of HIV-1 nucleocapsid protein and Gag or Gag-derived proteins: biological implications |
| Q40565764 | Generation of VSV-G pseudotyped lentiviral particles in 293T cells. |
| Q35635221 | Genetic Studies of the beta-hairpin loop of Rous sarcoma virus capsid protein. |
| Q36347240 | Genetic footprinting of a retroviral Gag gene suggests an important role in virus replication |
| Q36323002 | HIV Gag mimics the Tsg101-recruiting activity of the human Hrs protein. |
| Q34389522 | HIV p24 as scaffold for presenting conformational HIV Env antigens |
| Q58597952 | HIV-1 Protease Uses Bi-Specific S2/S2' Subsites to Optimize Cleavage of Two Classes of Target Sites |
| Q34666010 | HIV-1 RNA dimerization: It takes two to tango |
| Q34175976 | HIV-1 capsid protein forms spherical (immature-like) and tubular (mature-like) particles in vitro: structure switching by pH-induced conformational changes |
| Q30804067 | HIV-1 uses dynamic capsid pores to import nucleotides and fuel encapsidated DNA synthesis |
| Q42668114 | Head-to-tail dimers and interdomain flexibility revealed by the crystal structure of HIV-1 capsid protein (p24) complexed with a monoclonal antibody Fab. |
| Q37853442 | Helix-mediated protein--protein interactions as targets for intervention using foldamers |
| Q27485400 | Hepatitis C Virus-Like Particle Budding: Role of the Core Protein and Importance of Its Asp111 |
| Q39272732 | High-resolution structure of a retroviral capsid hexameric amino-terminal domain |
| Q57050142 | High-resolution structures of HIV-1 Gag cleavage mutants determine structural switch for virus maturation |
| Q39549065 | Higher-order structure of the Rous sarcoma virus SP assembly domain |
| Q34624282 | Homology-based identification of capsid determinants that protect HIV1 from human TRIM5α restriction |
| Q24303183 | Human ESCRT-II complex and its role in human immunodeficiency virus type 1 release |
| Q37060306 | Human Immunodeficiency Virus Type 1 N-Terminal Capsid Mutants Containing Cores with Abnormally High Levels of Capsid Protein and Virtually No Reverse Transcriptase |
| Q44080031 | Human immunodeficiency virus type 1 Gag assembly through assembly intermediates |
| Q33845811 | Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells |
| Q36857103 | Human immunodeficiency virus type 1 assembly, release, and maturation. |
| Q35104668 | Hydrogen bonding at a conserved threonine in lentivirus capsid is required for virus replication |
| Q42361670 | Hydrogen/Deuterium Exchange Analysis of HIV-1 Capsid Assembly and Maturation |
| Q39606338 | Hydrophobic amino acids in the human immunodeficiency virus type 1 p2 and nucleocapsid proteins can contribute to the rescue of deleted viral RNA packaging signals. |
| Q59350788 | IP6 Regulation of HIV Capsid Assembly, Stability, and Uncoating |
| Q57459053 | Identification of a Structural Element in HIV-1 Gag Required for Virus Particle Assembly and Maturation |
| Q24300554 | Identification of human MVB12 proteins as ESCRT-I subunits that function in HIV budding |
| Q41629680 | Identification of novel interactions in HIV-1 capsid protein assembly by high-resolution mass spectrometry. |
| Q41631451 | Image reconstructions of helical assemblies of the HIV-1 CA protein |
| Q35825095 | Impact of naturally occurring amino acid variations on the detection of HIV-1 p24 in diagnostic antigen tests. |
| Q35107346 | Impaired infectivity of ritonavir-resistant HIV is rescued by heat shock protein 90AB1. |
| Q30365424 | Imperfect DNA mirror repeats in the gag gene of HIV-1 (HXB2) identify key functional domains and coincide with protein structural elements in each of the mature proteins. |
| Q40928746 | In vitro assembly of human immunodeficiency virus type 1 Gag protein |
| Q33767623 | In vitro assembly of the Rous Sarcoma Virus capsid protein into hexamer tubes at physiological temperature. |
| Q40605953 | In vitro assembly of virus-like particles of a gammaretrovirus, the murine leukemia virus XMRV. |
| Q33653475 | In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain. |
| Q38716274 | Inhibition of HIV-1 Maturation via Small-Molecule Targeting of the Amino-Terminal Domain in the Viral Capsid Protein |
| Q56335987 | Inositol phosphates are assembly co-factors for HIV-1 |
| Q34448034 | Interaction of HIV-1 Gag with the clathrin-associated adaptor AP-2. |
| Q34232978 | Interaction of moloney murine leukemia virus capsid with Ubc9 and PIASy mediates SUMO-1 addition required early in infection. |
| Q24295223 | Interaction of the HIV-1 intasome with transportin 3 protein (TNPO3 or TRN-SR2) |
| Q35691189 | Interactions between HIV-1 Gag molecules in solution: an inositol phosphate-mediated switch |
| Q34360874 | Intrinsic immunity: a front-line defense against viral attack |
| Q27931628 | Investigation by atomic force microscopy of the structure of Ty3 retrotransposon particles |
| Q44925938 | Isolation and characterization of the Mason-Pfizer monkey virus p12 protein |
| Q47314618 | Key interactions in HIV-1 maturation identified by hydrogen-deuterium exchange. |
| Q39684054 | Kinetic analysis of the role of intersubunit interactions in human immunodeficiency virus type 1 capsid protein assembly in vitro |
| Q45424165 | Kinetic and mass spectrometry-based investigation of human immunodeficiency virus type 1 assembly and maturation |
| Q28487670 | Large-scale functional purification of recombinant HIV-1 capsid |
| Q35477673 | Lentiviral Gag assembly analyzed through the functional characterization of chimeric simian immunodeficiency viruses expressing different domains of the feline immunodeficiency virus capsid protein |
| Q35965461 | Live-cell observation of cytosolic HIV-1 assembly onset reveals RNA-interacting Gag oligomers |
| Q33809347 | Mapping and characterization of the N-terminal I domain of human immunodeficiency virus type 1 Pr55(Gag). |
| Q33852559 | Maturation-induced conformational changes of HIV-1 capsid protein and identification of two high affinity sites for cyclophilins in the C-terminal domain |
| Q41450212 | Molecular characterization of HIV-1 genome in fission yeast Schizosaccharomyces pombe |
| Q38021264 | Molecular recognition in the human immunodeficiency virus capsid and antiviral design |
| Q64247477 | Multiple Roles of HIV-1 Capsid during the Virus Replication Cycle |
| Q40326740 | Mutant murine leukemia virus Gag proteins lacking proline at the N-terminus of the capsid domain block infectivity in virions containing wild-type Gag. |
| Q35023995 | Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, gag-gag interactions, gag-membrane binding, and virion maturation |
| Q40174170 | Mutational analysis of the N-terminal domain of Moloney murine leukemia virus capsid protein |
| Q24815688 | Mutations affecting cleavage at the p10-capsid protease cleavage site block Rous sarcoma virus replication |
| Q39763774 | Mutations in the spacer peptide and adjoining sequences in Rous sarcoma virus Gag lead to tubular budding |
| Q38812540 | Mutations of Conserved Residues in the Major Homology Region Arrest Assembling HIV-1 Gag as a Membrane-Targeted Intermediate Containing Genomic RNA and Cellular Proteins |
| Q40078275 | Myristoylation is required for human immunodeficiency virus type 1 Gag-Gag multimerization in mammalian cells |
| Q39580545 | N-Terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles |
| Q33624690 | Novel approaches to inhibiting HIV-1 replication. |
| Q33957533 | Novel postentry inhibitor of human immunodeficiency virus type 1 replication screened by yeast membrane-associated two-hybrid system |
| Q38346922 | Nucleic acid binding-induced Gag dimerization in the assembly of Rous sarcoma virus particles in vitro |
| Q39685711 | Nucleic acid-independent retrovirus assembly can be driven by dimerization |
| Q34033167 | Nucleocapsid protein of human immunodeficiency virus as a model protein with chaperoning functions and as a target for antiviral drugs |
| Q56342048 | Nup153 Unlocks the Nuclear Pore Complex for HIV-1 Nuclear Translocation in Non-dividing Cells |
| Q30364667 | Optimizing scaleup yield for protein production: Computationally Optimized DNA Assembly (CODA) and Translation Engineering. |
| Q30499709 | Ordered assembly of murine leukemia virus capsid protein on lipid nanotubes directs specific binding by the restriction factor, Fv1 |
| Q26771739 | Pharmacological intervention of HIV-1 maturation |
| Q33743971 | Potential role for CA-SP in nucleating retroviral capsid maturation |
| Q30276687 | Primate TRIM5 proteins form hexagonal nets on HIV-1 capsids |
| Q27342743 | Protease cleavage leads to formation of mature trimer interface in HIV-1 capsid |
| Q33255022 | Proteomic analysis of the major envelope and nucleocapsid proteins of white spot syndrome virus |
| Q47107077 | Quenching protein dynamics interferes with HIV capsid maturation. |
| Q33787084 | Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding |
| Q30850215 | Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease |
| Q45422412 | Rescue of internal scaffold-deleted Mason-Pfizer monkey virus particle production by plasma membrane targeting |
| Q41244531 | Retroviral capsid assembly: a role for the CA dimer in initiation |
| Q30873476 | Retrovirus capsid protein assembly arrangements |
| Q26752271 | Retrovirus maturation-an extraordinary structural transformation |
| Q34354654 | Reversible binding of recombinant human immunodeficiency virus type 1 gag protein to nucleic acids in virus-like particle assembly in vitro |
| Q45388085 | Role of capsid sequence and immature nucleocapsid proteins p9 and p15 in Human Immunodeficiency Virus type 1 genomic RNA dimerization |
| Q39539672 | Role of the Rous sarcoma virus p10 domain in shape determination of gag virus-like particles assembled in vitro and within Escherichia coli |
| Q34499377 | Role of transmitted Gag CTL polymorphisms in defining replicative capacity and early HIV-1 pathogenesis |
| Q33794223 | Roles of matrix, p2, and N-terminal myristoylation in human immunodeficiency virus type 1 Gag assembly |
| Q38289565 | Rous sarcoma virus Gag protein-oligonucleotide interaction suggests a critical role for protein dimer formation in assembly |
| Q39065469 | Second site reversion of a mutation near the amino terminus of the HIV-1 capsid protein |
| Q35076692 | Second-site compensatory mutations of HIV-1 capsid mutations |
| Q39362257 | Second-site suppressors of HIV-1 capsid mutations: restoration of intracellular activities without correction of intrinsic capsid stability defects |
| Q33844210 | Second-site suppressors of Rous sarcoma virus Ca mutations: evidence for interdomain interactions |
| Q39595748 | Separate assembly and transport domains within the Gag precursor of Mason-Pfizer monkey virus |
| Q37060336 | Simian-human immunodeficiency virus escape from cytotoxic T-lymphocyte recognition at a structurally constrained epitope. |
| Q35070372 | Simulated self-assembly of the HIV-1 capsid: protein shape and native contacts are sufficient for two-dimensional lattice formation |
| Q40669940 | Simultaneous mutations in CA and Vif of Maedi-Visna virus cause attenuated replication in macrophages and reduced infectivity in vivo |
| Q38943171 | Stabilization of the β-hairpin in Mason-Pfizer monkey virus capsid protein- a critical step for infectivity |
| Q33769181 | Structural analysis of HIV-1 maturation using cryo-electron tomography |
| Q30349736 | Structural and dynamics studies of the D54A mutant of human T cell leukemia virus-1 capsid protein. |
| Q40722958 | Structural requirements for recognition of the human immunodeficiency virus type 1 core during host restriction in owl monkey cells |
| Q36187632 | Structure of a Spumaretrovirus Gag Central Domain Reveals an Ancient Retroviral Capsid |
| Q34688740 | Structure of a novel shoulder-to-shoulder p24 dimer in complex with the broad-spectrum antibody A10F9 and its implication in capsid assembly |
| Q27637386 | Structure of equine infectious anemia virus matrix protein |
| Q27647971 | Structure of the Antiviral Assembly Inhibitor CAP-1 Complex with the HIV-1 CA Protein |
| Q27666307 | Structure of the HIV-1 Full-Length Capsid Protein in a Conformationally Trapped Unassembled State Induced by Small-Molecule Binding |
| Q27696126 | Structure of the immature HIV-1 capsid in intact virus particles at 8.8 Å resolution |
| Q27681296 | Structure of the immature retroviral capsid at 8 Å resolution by cryo-electron microscopy |
| Q36958798 | Suboptimal inhibition of protease activity in human immunodeficiency virus type 1: effects on virion morphogenesis and RNA maturation |
| Q43106534 | TY3 GAG3 protein forms ordered particles in Escherichia coli |
| Q33785479 | The C-terminal half of the human immunodeficiency virus type 1 Gag precursor is sufficient for efficient particle assembly. |
| Q34350076 | The Mason-Pfizer monkey virus internal scaffold domain enables in vitro assembly of human immunodeficiency virus type 1 Gag. |
| Q39606189 | The NH2-terminal domain of the human T-cell leukemia virus type 1 capsid protein is involved in particle formation |
| Q39180622 | The NTD-CTD intersubunit interface plays a critical role in assembly and stabilization of the HIV-1 capsid |
| Q24294993 | The Protein Network of HIV Budding |
| Q34742382 | The TY3 Gag3 spacer controls intracellular condensation and uncoating |
| Q37613762 | The capsid protein of human immunodeficiency virus: intersubunit interactions during virus assembly |
| Q33727091 | The capsid-spacer peptide 1 Gag processing intermediate is a dominant-negative inhibitor of HIV-1 maturation |
| Q27009643 | The choreography of HIV-1 proteolytic processing and virion assembly |
| Q37492757 | The conserved carboxy terminus of the capsid domain of human immunodeficiency virus type 1 gag protein is important for virion assembly and release |
| Q34189436 | The cysteine residues of HIV-1 capsid regulate oligomerization and cyclophilin A-induced changes |
| Q43095035 | The dimerization domain of the HIV-1 capsid protein binds a capsid protein-derived peptide: a biophysical characterization |
| Q28486018 | The effect of chemical chaperones on the assembly and stability of HIV-1 capsid protein |
| Q42031692 | The effect of point mutations within the N-terminal domain of Mason-Pfizer monkey virus capsid protein on virus core assembly and infectivity. |
| Q24297840 | The human endosomal sorting complex required for transport (ESCRT-I) and its role in HIV-1 budding |
| Q36614059 | The interdomain linker region of HIV-1 capsid protein is a critical determinant of proper core assembly and stability |
| Q36543685 | The maturational refolding of the β-hairpin motif of equine infectious anemia virus capsid protein extends its helix α1 at capsid assembly locus |
| Q33326633 | The p12 domain is unstructured in a murine leukemia virus p12-CA(N) Gag construct |
| Q73836959 | The pH dependence of HIV-1 capsid assembly and its interaction with cyclophilin A |
| Q30437103 | The structural biology of HIV assembly |
| Q36656440 | The structural biology of HIV-1: mechanistic and therapeutic insights |
| Q33632676 | Towards the structure of the human immunodeficiency virus: divide and conquer |
| Q34141649 | Tripeptide interference with human immunodeficiency virus type 1 morphogenesis |
| Q24291784 | Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding |
| Q41108293 | Two mutations in the vif gene of maedi-visna virus have different phenotypes, indicating more than one function of Vif. |
| Q27931343 | Ty3 capsid mutations reveal early and late functions of the amino-terminal domain |
| Q43546924 | Urea equilibrium unfolding of the major core protein of the retrovirus feline immunodeficiency virus and its tryptophan mutants |
| Q39549710 | Vif and the p55(Gag) polyprotein of human immunodeficiency virus type 1 are present in colocalizing membrane-free cytoplasmic complexes |
| Q38100451 | Viral precursor polyproteins: keys of regulation from replication to maturation |
| Q30648737 | Virus assembly |
| Q24642446 | Virus maturation as a new HIV-1 therapeutic target |
| Q33718140 | Virus particle core defects caused by mutations in the human immunodeficiency virus capsid N-terminal domain |
| Q37291661 | Visualization of a missing link in retrovirus capsid assembly |
| Q27655910 | X-ray structures of the hexameric building block of the HIV capsid |
| Q30009320 | eEF2 and Ras-GAP SH3 domain-binding protein (G3BP1) modulate stress granule assembly during HIV-1 infection |
| Q34331870 | trans-Complementation rescue of cyclophilin A-deficient viruses reveals that the requirement for cyclophilin A in human immunodeficiency virus type 1 replication is independent of its isomerase activity |
Search more.